Inge E.T. van den Berg

1.9k citations

26 papers · 1.4k indexed · h-index 18

Molecular Biology
Surgery top 10%
Endocrinology, Diabetes and Metabolism top 5%
Clinical Biochemistry top 1%
Oncology top 10%

Co-authors: Ruud Berger Leo W. J. Klomp Helga E.M. Malingré Simon Eaton S. Krywawych Khalid Hussain Peter T. Clayton Vipan Datta
Topics: Metabolism and Genetic Disorders (12 papers)Amino Acid Enzymes and Metabolism (6 papers)Drug Transport and Resistance Mechanisms (4 papers)
Cited by: Clinical Biochemistry Biochemistry Endocrinology, Diabetes and Metabolism
Journals: Journal of Clinical Investigation Gastroenterology Hepatology
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Inge E.T. van den Berg

26 papers receiving 1.3k citations

Peers

Countries citing papers authored by Inge E.T. van den Berg

Since Specialization

Citations

This map shows the geographic impact of Inge E.T. van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge E.T. van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge E.T. van den Berg more than expected).

Fields of papers citing papers by Inge E.T. van den Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge E.T. van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge E.T. van den Berg. The network helps show where Inge E.T. van den Berg may publish in the future.

Co-authorship network of co-authors of Inge E.T. van den Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Inge E.T. van den Berg. A scholar is included among the top collaborators of Inge E.T. van den Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge E.T. van den Berg. Inge E.T. van den Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Considering Fabry, but Diagnosing MPS I: Difficulties in the Diagnostic Process 2012 ·JIMD Reports ·Eveline J. Langereis,Inge E.T. van den Berg,Dicky Halley,B. J. H. M. Poorthuis,Frédéric M. Vaz,John H. J. Wokke,Gabor E. Linthorst	3
2	Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics 2009 ·Human Mutation ·(unknown),Tom J. de Koning,(unknown),Inge E.T. van den Berg,Ruud Berger,Leo W. J. Klomp	37
3	Kidneys of Mice With Hereditary Tyrosinemia Type I Are Extremely Sensitive to Cytotoxicity 2006 ·Pediatric Research ·(unknown),(unknown),Leo W. J. Klomp,Ruud Berger,Inge E.T. van den Berg	12
4	Tyrosinaemia type I—de novo mutation in liver tissue suppressing an inborn splicing defect 2005 ·Journal of Molecular Medicine ·Yngve Thomas Bliksrud,(unknown),Per Arne Andresen,Inge E.T. van den Berg,E. A. Kvittingen	19
5	Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11 2004 ·Gastroenterology ·Saskia W. C. van Mil,Wendy L. van der Woerd,(unknown),Ekkehard Sturm,Peter L. M. Jansen,Laura N. Bull,Inge E.T. van den Berg,Ruud Berger,Roderick H.J. Houwen,Leo W. J. Klomp	218
6	Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death 2004 ·Hepatology ·Arndt Vogel,Inge E.T. van den Berg,Muhsen Al-Dhalimy,John D. Groopman,Ching-Nan Ou,Olga P. Ryabinina,Mihail S. Iordanov,Milton J. Finegold,Markus Grompe	43
7	FIC1 Is Expressed at Apical Membranes of Different Epithelial Cells in the Digestive Tract and Is Induced in the Small Intestine During Postnatal Development of Mice 2004 ·Pediatric Research ·Saskia W. C. van Mil,M. Oort,Inge E.T. van den Berg,Ruud Berger,Roderick H.J. Houwen,Leo W. J. Klomp	47
8	Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1 2004 ·Kidney International ·(unknown),(unknown),Helga E.M. Malingré,(unknown),Markus Grompe,(unknown),Ruud Berger,Inge E.T. van den Berg	6
9	Extensive changes in liver gene expression induced by Hereditary Tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) 2003 ·Journal of Hepatology ·(unknown),(unknown),(unknown),(unknown),Leo W. J. Klomp,Ruud Berger,Inge E.T. van den Berg	24
10	Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion 2001 ·Journal of Clinical Investigation ·Peter T. Clayton,Simon Eaton,A Aynsley‐Green,(unknown),Khalid Hussain,S. Krywawych,Vipan Datta,Helga E.M. Malingré,Ruud Berger,Inge E.T. van den Berg	208
11	Molecular Characterization of 3-Phosphoglycerate Dehydrogenase Deficiency—a Neurometabolic Disorder Associated with Reduced L-Serine Biosynthesis 2000 ·The American Journal of Human Genetics ·Leo W. J. Klomp,Tom J. de Koning,Helga E.M. Malingré,(unknown),(unknown),Frans L. Opdam,Marinus Duran,Jaak Jaeken,Mercè Pineda,Lionel Van Maldergem,Bwee Tien Poll‐The,Inge E.T. van den Berg,Ruud Berger	86
12	A Novel Disorder of N-Glycosylation Due to Phosphomannose Isomerase Deficiency 1998 ·Biochemical and Biophysical Research Communications ·Tom J. de Koning,L. Dorland,O. P. van Diggelen,(unknown),(unknown),W.L. van Noort,(unknown),(unknown),Inge E.T. van den Berg,Gerrit J. Gerwig,R. Berger,Bwee Tien Poll‐The	92
13	Recurrent nonimmune hydrops fetalis associated with carbohydrate‐deficient glycoprotein syndrome 1998 ·Journal of Inherited Metabolic Disease ·Tom J. de Koning,Mona C. Toet,L. Dorland,L.S. de Vries,Inge E.T. van den Berg,(unknown),Bwee Tien Poll‐The	46
14	Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries 1998 ·Human Mutation ·(unknown),Inge E.T. van den Berg,(unknown),(unknown),Hans Kristian Ploos van Amstel,(unknown)	1
15	Autosomal Recessive Phosphorylase Kinase Deficiency in Liver, Caused by Mutations in the Gene Encoding the β Subunit (PHKB) 1997 ·The American Journal of Human Genetics ·Inge E.T. van den Berg,(unknown),Johannis B.C. de Klerk,Otto P. van Diggelen,Helga E.M. Malingré,(unknown),Ruud Berger	19
16	Autosomal Recessive Liver Phosphorylase Kinase Deficiency Caused by a Novel Splice-Site Mutation in the Gene Encoding the Liver Gamma Subunit (PHKG2) 1997 ·Biochemical and Biophysical Research Communications ·(unknown),(unknown),U. Wendel,R Gitzelmann,R. Berger,Inge E.T. van den Berg	20
17	Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship 1996 ·Human Genetics ·Hans Kristian Ploos van Amstel,(unknown),(unknown),Janine Roijers,Tamara Peelen,Inge E.T. van den Berg,Bwee Tien Poll‐The,E. A. Kvittingen,Ruud Berger	45
18	Human Short-Chain L-3-Hydroxyacyl-CoA Dehydrogenase: Cloning and Characterization of the Coding Sequence 1996 ·Biochemical and Biophysical Research Communications ·(unknown),Inge E.T. van den Berg,Helga E.M. Malingré,An K. Stroobants,(unknown),Ruud Berger	48
19	Hematuria caused by renal medullary crest necrosis in a horse 1987 ·Compendium on Continuing Education for The Practicing Veterinarian ·(unknown),Inge E.T. van den Berg	2
20	A Pathologist's View of the Scouring Calf 1981 ·NDSU Repository (North Dakota State University) ·Inge E.T. van den Berg	1

About Inge E.T. van den Berg

Inge E.T. van den Berg is a scholar working on Clinical Biochemistry, Biochemistry and Equine, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (12 papers), Amino Acid Enzymes and Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Clinical Biochemistry (291 citations), Biochemistry (152 citations) and Endocrinology, Diabetes and Metabolism (305 citations). Inge E.T. van den Berg has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Ruud Berger, Leo W. J. Klomp, Helga E.M. Malingré, Simon Eaton, S. Krywawych, Khalid Hussain, Peter T. Clayton, Vipan Datta, A Aynsley‐Green and Roderick H.J. Houwen. Their work appears in journals such as Journal of Clinical Investigation, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact